Audit Plan of Johnson & Johnson

Submitted by: Submitted by

Views: 1051

Words: 3359

Pages: 14

Category: Business and Industry

Date Submitted: 11/12/2010 06:37 AM

Report This Essay

Group Members:

Khrystyn Owens

Erin Riley

Shameka White

Janet Wilson

November 11, 2010

ACCT 4117

Johnson & Johnson (J&J) is the world’s largest and diverse base manufacturer of health care products. J&J objective is to provide quality health products and services to improve peoples’ quality of life globally.

The company conducts business in virtually all countries worldwide with the primary focus on products related to human health and well-being. Johnson & Johnson products are classified into different division: consumer products, medical devices and diagnostics, and prescription products. Because J & J offers a variety of products and services, the following sections will describe some of the products in the consumer and pharmaceutical divisions.

Consumer Products

Baby Care: Johnson’s Bedtime, Johnson’s Soothing Naturals, Penaten

Skin and Hair Care: Clean & Clear, Nuetrogena, Aveeno

Wound Care and Topicals: Band Aid Brand Adhesive Bandages, Neosporin, Purell

Oral Health Care: Listerine, Reach

Women’s Health: Stay free

Over the Counter Medicines: Tylenol, Motrin, Benadryl, Sudafed

Nutrionals: Splenda, Lactaid

Vision Care: Visine, AcuvueBrad Contact Lenses

Prescription Products

Axert, Concerta, Leustatin, Regranex, Doribax, Doxil, Velcade

The raw materials used by readily available from many sources.

Consumer Products Ingredients:

Aveeno: Water, Glycerin, Cetyl Alcohol, Olive, Shea Butter

Band-Aid: PE, PVC, PU, Nonwoven, Non Stretchable Cloth, Absorbent Pad, Silicon Paper, Embossed Film

Listerine: Alcohol, Sodium Phosphate, Sucralose, Sodium Fluoride

Johnson’s Baby Lotion: Propylene Glycol, Myristyl Myristrate, Carbomer, Frangance

Tylenol: Acetaminophen, Dextromethorphan, Doxylamine succinate, Phenylephrine, HCI

The 10-K report for 2009 reported J&J sales as$61,897,000,000. More specifically, medical and diagnostics segment sales were$23,600,000,000, pharmaceutical segment sales were $22,500,000,000, and consumer segment...